Related Experiment Videos
[Pulmonary adverse effect after amiodarone treatment--case report]
D Ziora1, J Kamiński, J Kozielski
1Klinika Ftizjopneumonologii Slaskiej Akademii Medycznej w Zabrzu.
Pneumonologia I Alergologia Polska
|November 26, 1999
Summary
A case study highlights amiodarone-induced pulmonary toxicity. Doubling the amiodarone dose led to toxicity, which improved after drug withdrawal and corticosteroid treatment.
Area of Science:
- Cardiology
- Pulmonology
- Pharmacology
Background:
- Amiodarone is a widely used antiarrhythmic drug.
- Pulmonary toxicity is a known adverse effect of amiodarone.
- The case focuses on amiodarone's impact on lung health.
Observation:
- A 64-year-old male developed pulmonary toxicity after four years of amiodarone therapy.
- Toxicity emerged when the daily dose was increased from 200 mg to 400 mg.
- Initial improvement was noted after discontinuing amiodarone, with further remission after corticosteroid introduction.
Findings:
- Increased dosage of amiodarone can precipitate pulmonary toxicity.
- Discontinuation of amiodarone can lead to clinical and functional recovery.
- Corticosteroids may aid in radiological remission of amiodarone-induced lung injury.
Implications:
- Clinicians should be vigilant about amiodarone dosage adjustments.
- Early recognition and drug withdrawal are crucial for managing amiodarone pulmonary toxicity.
- Corticosteroid therapy may be beneficial in specific cases of amiodarone-induced lung disease.